Transcatheter aortic valve implantation (TAVI) is now utilised as a less invasive alternative to
surgical aortic valve replacement (SAVR) across the whole spectrum of surgical risk. Long …

Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) is currently indicated for
the treatment of failed surgical tissue valves in patients determined to be at high surgical risk …

Background Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) is
increasingly used to treat degenerated surgical bioprostheses. Bioprosthetic valve fracture …

Objectives The aim of this study was to evaluate flow dynamics in the aortic sinus and the
neosinus (NS) after transcatheter heart valve (THV) implantation in valve-in-valve (ViV) …

Background Bioprosthetic valve fracture (BVF) can be used to improve transcatheter heart
valve (THV) haemodynamics following a valve-in-valve (ViV) intervention. However, whether …

Introduction Valve-in-valve (VIV) transcatheter valve replacement has emerged as a feasible
and potentially safer treatment option for failed bioprosthetic surgical valves (BSVs) …

Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves
(VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve …

Background There are limited data on the effect of bioprosthetic valve remodeling (BVR) on
transcatheter heart valve (THV) expansion and function following valve-in-valve (VIV) …

The use of transcatheter aortic valve implantation (TAVI) has greatly increased over the past
2 decades and now has overtaken surgical aortic valve replacement. We have limited data …

Objectives To evaluate outcome and its predictors of bioprosthetic valve fracture (BVF) in
patients undergoing valve‐in‐valve transcatheter aortic valve replacement (VIV‐TAVR) …